Targetable genetic features of primary testicular and primary central nervous system lymphomas.

Blood
Authors
Keywords
Abstract

Primary central nervous system lymphomas (PCNSLs) and primary testicular lymphomas (PTLs) are extranodal large B-cell lymphomas (LBCLs) with inferior responses to current empiric treatment regimens. To identify targetable genetic features of PCNSL and PTL, we characterized their recurrent somatic mutations, chromosomal rearrangements, copy number alterations (CNAs), and associated driver genes, and compared these comprehensive genetic signatures to those of diffuse LBCL and primary mediastinal large B-cell lymphoma (PMBL). These studies identify unique combinations of genetic alterations in discrete LBCL subtypes and subtype-selective bases for targeted therapy. PCNSLs and PTLs frequently exhibit genomic instability, and near-uniform, often biallelic, CDKN2A loss with rare TP53 mutations. PCNSLs and PTLs also use multiple genetic mechanisms to target key genes and pathways and exhibit near-uniform oncogenic Toll-like receptor signaling as a result of MYD88 mutation and/or NFKBIZ amplification, frequent concurrent B-cell receptor pathway activation, and deregulation of BCL6. Of great interest, PCNSLs and PTLs also have frequent 9p24.1/PD-L1/PD-L2 CNAs and additional translocations of these loci, structural bases of immune evasion that are shared with PMBL.

Year of Publication
2016
Journal
Blood
Volume
127
Issue
7
Pages
869-81
Date Published
2016 Feb 18
ISSN
1528-0020
URL
DOI
10.1182/blood-2015-10-673236
PubMed ID
26702065
PubMed Central ID
PMC4760091
Links
Grant list
P01 AI056299 / AI / NIAID NIH HHS / United States
R01 CA161026 / CA / NCI NIH HHS / United States